Jun 15, 2026 · 7 min

SpaceX value tops $2.4 trillion while biotech and retail stocks slide

SpaceX Jumps, Adaptive Biotechnologies Slides, Dave & Buster's Lower

The divergence between high-flying private aerospace valuations and struggling retail and biotech sectors highlights shifting investor risk appetites.

3 key takeaways

1SpaceX valuation surges past two point four trillion dollars following a massive post-debut trading rally.
2Adaptive Biotechnologies shares slide in aftermarket trading following a new convertible notes offering.
3Dave and Buster's misses first-quarter revenue expectations to round out a mixed day for market movers.

Don't miss

Carmen Reineke breaks down the scale of SpaceX's valuation surge and the implications of Elon Musk's ownership stake.

The brief

SpaceX dominates the market conversation as its massive post-debut rally pushes the aerospace company's valuation past the $2.4 trillion mark, highlighting investor appetite for private space exploration giants.

While SpaceX surges, other market sectors face headwinds. Adaptive Biotechnologies slides after announcing a convertible notes offering, and Dave & Buster's struggles to reassure investors after a disappointing first-quarter revenue miss.

Bloomberg News reporter Carmen Reineke joins hosts Carol Massar and Tim Stenovec to break down the trading activity, focusing on Elon Musk's significant ownership stake and what it means for the company's control.

What was said on this episode

10 statements · 5 positive · 2 negative · 3 neutral

Carmen Reinekeon SpaceX sharesPositive1:11
SpaceX shares rose 20%, extending a 19% prior-day rally.
“Shares up 20% today, extending Friday's 19% rally.”
Listen at 1:11
Carmen Reinekeon SpaceXPositive1:16
SpaceX gained $412 billion in market value.
“This added $412 billion in market value to this stock.”
Listen at 1:16
Carmen Reinekeon SpaceX valuation relative to AmazonPositive1:26
SpaceX is approaching Amazon's valuation.
“it's actually gaining ground, getting much closer to surpassing Amazon, which has about 2.7 trillion valuation.”
Listen at 1:26
Carmen Reinekeon SpaceXPositive1:35
SpaceX ended the day with a $2.5 trillion valuation.
“SpaceX ended the day at 2.5 trillion.”
Listen at 1:35
Tim Stenovecon Elon Musk's SpaceX sharesPositive1:48
Elon Musk owns 11.5% of SpaceX's traded shares, worth $136.7 billion.
“He owns 11 and a half percent of them. He's the largest shareholder. The market value of those shares is 136.7 billion.”
Listen at 1:48
Carmen Reinekeon SpaceX short-position dataNeutral2:10
Short-position data for SpaceX should begin arriving within days.
“So I think data starts coming in in the next couple of days.”
Listen at 2:10
Carmen Reinekeon SpaceX public floatNeutral2:16
SpaceX has a low public float.
“Especially we have low float here.”
Listen at 2:16
Carmen Reinekeon Adaptive BiotechnologiesNegative3:29
Adaptive Biotechnologies shares fell about 6.4% aftermarket.
“shares are down about 6, 6.4% right now.”
Listen at 3:29
Carmen Reinekeon Adaptive Biotechnologies convertible senior notes offeringNeutral3:34
Adaptive Biotechnologies plans to offer $250 million in convertible senior notes.
“this company said it plans to offer 250 million convertible senior notes.”
Listen at 3:34
Carmen Reinekeon Dave & Buster's sharesNegative4:12
Dave & Buster's shares fell 4.3% after hours.
“shares are down 4.3% right now in after hours.”
Listen at 4:12

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Featuring

CRCarmen Reineke

Mentioned

SSpaceX

Adaptive Biotechnologies

Dave & Buster's

Elon Reeve Musk

Books & mentions

Bloomberg: Business News Daily

Stay updated on global business, finance news, and daily market data via Bloomberg's mobile platform

Listen to the full episode and explore every guest, topic, and moment on PodLume.

Listen to the full episode Or get the iOS app